Home/Filings/4/0001209191-22-042201
4//SEC Filing

Wochok Zachary S. 4

Accession 0001209191-22-042201

CIK 0001441693other

Filed

Jul 13, 8:00 PM ET

Accepted

Jul 14, 8:33 PM ET

Size

12.1 KB

Accession

0001209191-22-042201

Insider Transaction Report

Form 4
Period: 2022-07-12
Transactions
  • Award

    Common Stock

    2022-07-12+429,081429,881 total
  • Disposition to Issuer

    Common Stock

    2022-07-12429,8810 total
  • Disposition to Issuer

    Common Stock

    2022-07-125,0000 total(indirect: By Trust)
  • Exercise/Conversion

    Restricted Stock Units

    2022-07-12429,0810 total
    Common Stock (429,081 underlying)
Footnotes (6)
  • [F1]Any unvested restricted stock units became vested and all restricted stock units were delivered to the Reporting Person, pursuant to the grant terms, immediately prior to the change of control transaction (the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 16, 2022, by and between Bioceres Crop Solutions Corp., BCS Merger Sub, Inc., and Issuer (the "Merger Agreement").
  • [F2]The settlement of restricted stock units is being reported as one award; however, a number of awards of restricted stock units, as reported in prior Forms 4, are being settled. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, details of the awards previously granted and settled as set forth in this footnote to this Form 4.
  • [F3]Disposed of pursuant to the Merger Agreement in exchange for 37,829 Ordinary Shares of BIOX having a market value of $9.44 per share on the effective date of the Merger.
  • [F4]Disposed of pursuant to the Merger Agreement in exchange for 440 Ordinary Shares of BIOX having a market value of $9.44 per share on the effective date of the Merger.
  • [F5]Each restricted stock unit represented a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock.
  • [F6]Any unvested restricted stock units vested completely immediately prior to the Merger, and the underlying shares were delivered to the Reporting Person immediately prior to the Merger in accordance with the terms of the grants.

Issuer

MARRONE BIO INNOVATIONS INC

CIK 0001441693

Entity typeother

Related Parties

1
  • filerCIK 0001671603

Filing Metadata

Form type
4
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 8:33 PM ET
Size
12.1 KB